Phase 4 Efficacy and Safety Study of Cubicin® With and Without Combination Therapy in S. Aureus Infective Endocarditis (SAIE)
Clinical trial NCT00638157 · TERMINATED
Trial details
- NCT number
- NCT00638157
- Sponsor
- Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)
- Status
- TERMINATED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2009-02-13
- Primary completion
- 2011-11-09
- Enrollment
- 24
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.